Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Yuko Asari, Kazunori Kageyama, Yuki Nakada, Mizuki Tasso, Shinobu Takayasu, Kanako Niioka, Noriko Ishigame & Makoto Daimon. (2017) Inhibitory effects of a selective Jak2 inhibitor on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT20 cells. OncoTargets and Therapy 10, pages 4329-4338.
Read now
Read now
Denis Ciato, Aizhar G. Mumbach, Marcelo Paez-Pereda & Günter K. Stalla. (2017) Currently used and investigational drugs for Cushing´s disease. Expert Opinion on Investigational Drugs 26:1, pages 75-84.
Read now
Read now
Sara G Creemers, Leo J Hofland, Steven WJ Lamberts & Richard A Feelders. (2015) Cushing’s syndrome: an update on current pharmacotherapy and future directions. Expert Opinion on Pharmacotherapy 16:12, pages 1829-1844.
Read now
Read now
Edgar G Durán-Pérez, Oscar T Moreno-Loza, German Carrasco-Tobón & Antonio Segovia-Palomo. (2012) Optimal management of Cushing syndrome. Research and Reports in Endocrine Disorders 2, pages 19-30.
Read now
Read now
David E Schteingart. (2012) Drugs in the medical treatment of Cushing's syndrome – an update on mifepristone and pasireotide. Expert Opinion on Emerging Drugs 17:3, pages 279-283.
Read now
Read now
R Krysiak, A Kędzia & B Okopień. (2012) CYCLIC CUSHING’S SYNDROME. Acta Clinica Belgica 67:1, pages 30-33.
Read now
Read now
Evelin Schneider, Gwendolyn Gramer, Marc Schargus & Eugen Gramer. (2011) Visual Fields, Visual Acuity, and Driving Performance in Patients with Pituitary Adenoma before and after Surgery. Neuro-Ophthalmology 35:5-6, pages 259-263.
Read now
Read now
Tatiana Mancini, Teresa Porcelli & Andrea Giustina. (2010) Treatment of Cushing disease: overview and recent findings. Therapeutics and Clinical Risk Management 6, pages 505-516.
Read now
Read now
Articles from other publishers (49)
Xiao Zhang, Liangliang Meng, Yueyong Xiao & Zenan Chen. (2022) Case report: Radiofrequency ablation combined with biopsy for Cushing’s syndrome due to ectopic ACTH lesions in the lung. Frontiers in Oncology 12.
Crossref
Crossref
Renu Madan, Arun Yadav & Shikha Goyal. 2021. Evidence based practice in Neuro-oncology. Evidence based practice in Neuro-oncology
331
342
.
Victor Alexander Cueva-Quiroz, Jefferson Yunis-Aguinaga, Fernando Carlos Ramos-Espinoza, Flávio Ruas de Moraes & Julieta Rodini Engrácia de Moraes. (2020) Acute hypercortisolemia inhibits innate immune parameters in Piaractus mesopotamicus experimentally infected with Aeromonas hydrophila. Aquaculture 523, pages 735231.
Crossref
Crossref
Kazunori Kageyama, Yuko Asari, Yuko Sugimoto, Kanako Niioka & Makoto Daimon. (2020) Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation. Endocrine Journal 67:2, pages 177-184.
Crossref
Crossref
James R. Donald & Sophie L. Berrell. (2019)
Radical cyanomethylation
via
vinyl azide cascade-fragmentation
. Chemical Science 10:22, pages 5832-5836.
Crossref
Crossref
Yuko Asari, Kazunori Kageyama, Aya Sugiyama, Hikaru Kogawa, Kanako Niioka & Makoto Daimon. (2019) Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells. Endocrine Journal 66:6, pages 515-522.
Crossref
Crossref
Rossella Libé. (2018) Clinical and molecular prognostic factors in adrenocortical carcinoma. Minerva Endocrinologica 44:1.
Crossref
Crossref
Hideyuki Iwayama, Sho Hirase, Yuka Nomura, Tatsuo Ito, Hiroyuki Morita, Kazuo Otake, Akihisa Okumura & Junko Takagi. (2018) Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review. BMC Endocrine Disorders 18:1.
Crossref
Crossref
Lindsay M. Burt, Gita Suneja & Dennis C. Shrieve. 2018. Adult CNS Radiation Oncology. Adult CNS Radiation Oncology
19
35
.
Luz N. Franco Montoya, Talísia P. Martins, Rodrigo Y. Gimbo, Fábio S. Zanuzzo & Elisabeth C. Urbinati. (2017) β-Glucan-induced cortisol levels improve the early immune response in matrinxã ( Brycon amazonicus ). Fish & Shellfish Immunology 60, pages 197-204.
Crossref
Crossref
Kharis Burns, Darshika Christie-David & Jenny E Gunton. (2016) Fluconazole in the treatment of Cushing's disease. Endocrinology, Diabetes & Metabolism Case Reports 2016.
Crossref
Crossref
Nobumasa Ohara, Masanori Kaneko, Kazuhiro Sato, Hiroyuki Usuda, Junta Tanaka, Takashi Maekawa, Hironobu Sasano, Hideki Katakami, Kenzo Kaneko & Kyuzi Kamoi. (2016) Acute Exacerbation of Idiopathic Pulmonary Fibrosis Following Treatment for Cushing's Syndrome. Internal Medicine 55:4, pages 389-394.
Crossref
Crossref
Emily Rose Kirkpatrick, Judith Fleming & James Scurry. (2016) Sexual Arousal and Vulvar Angioedema Case of the Month From the International Society for the Study of Vulvovaginal Disease Case Consultation Committee. Journal of Lower Genital Tract Disease 20:1, pages 112-113.
Crossref
Crossref
John H. Suh, Sam T. Chao, Erin S. Murphy & Robert J. Weil. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology
502
520.e4
.
Rosario Pivonello, Monica De Leo, Alessia Cozzolino & Annamaria Colao. (2015) The Treatment of Cushing's Disease. Endocrine Reviews 36:4, pages 385-486.
Crossref
Crossref
Aya Sugiyama, Kazunori Kageyama, Shingo Murasawa, Noriko Ishigame, Kanako Niioka & Makoto Daimon. (2014) Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells. Pituitary 18:4, pages 542-553.
Crossref
Crossref
Eric Baudin. (2015) Adrenocortical Carcinoma. Endocrinology and Metabolism Clinics of North America 44:2, pages 411-434.
Crossref
Crossref
Kazunori Kageyama, Aya Sugiyama, Shingo Murasawa, Yuko Asari, Kanako Niioka, Yutaka Oki & Makoto Daimon. (2015) Aphidicolin inhibits cell proliferation <i>via</i> the p53-GADD45β pathway in AtT-20 cells. Endocrine Journal 62:7, pages 645-654.
Crossref
Crossref
Angela Stefanachi, Nina Hanke, Leonardo Pisani, Francesco Leonetti, Orazio Nicolotti, Marco Catto, Saverio Cellamare, Rolf W. Hartmann & Angelo Carotti. (2015) Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4′-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase. European Journal of Medicinal Chemistry 89, pages 106-114.
Crossref
Crossref
Elise Bouw, Martin Huisman, Sebastian J.C.M.M. Neggers, Axel P.N. Themmen, A.J. van der Lely & Patric J.D. Delhanty. (2014) Development of potent selective competitive-antagonists of the melanocortin type 2 receptor. Molecular and Cellular Endocrinology 394:1-2, pages 99-104.
Crossref
Crossref
Shingo Murasawa, Kazunori Kageyama, Aya Sugiyama, Noriko Ishigame, Kanako Niioka, Toshihiro Suda & Makoto Daimon. (2014) Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo. Molecular and Cellular Endocrinology 394:1-2, pages 37-46.
Crossref
Crossref
Diego Ferone, Claudia Pivonello, Giovanni Vitale, Maria Chiara Zatelli, Annamaria Colao & Rosario Pivonello. (2013) Molecular basis of pharmacological therapy in Cushing’s disease. Endocrine 46:2, pages 181-198.
Crossref
Crossref
Douma TN, Millan MJ, Verdouw PM, Oosting RS, Olivier B & Groenink L. (2014) Valproate improves prepulse inhibition deficits induced by corticotropin-releasing factor independent of GABAA and GABAB receptor activation. Neuropharmacology 79, pages 66-74.
Crossref
Crossref
Satoru Sakihara, Kazunori Kageyama, Satoshi Yamagata, Ken Terui, Makoto Daimon & Toshihiro Suda. (2014) A case of ectopic ACTH syndrome treated with intermittent administration of dopamine agonists. Endocrinology, Diabetes & Metabolism Case Reports 2014.
Crossref
Crossref
Hidenori FUKUOKA & Yutaka TAKAHASHI. (2014) The Role of Genetic and Epigenetic Changes in Pituitary Tumorigenesis. Neurologia medico-chirurgica 54:12, pages 943-957.
Crossref
Crossref
Akira Uruno, Akiko Saito-Hakoda, Atsushi Yokoyama, Naotaka Kogure, Ken Matsuda, Rehana Parvin, Kyoko Shimizu, Ikuko Sato, Masataka Kudo, Takeo Yoshikawa, Hiroyuki Kagechika, Yasumasa Iwasaki, Sadayoshi Ito & Akira Sugawara. (2014) Retinoic acid receptor-α up-regulates proopiomelanocortin gene expression in AtT20 corticotroph cells. Endocrine Journal 61:11, pages 1105-1114.
Crossref
Crossref
Nicholas A. Tritos & Beverly M.K. Biller. 2014. Clinical Neuroendocrinology. Clinical Neuroendocrinology
221
234
.
C. Pedro Becker. (2013) Tratamiento médico de tumores hipofisarios. Revista Médica Clínica Las Condes 24:5, pages 742-747.
Crossref
Crossref
John D. Carmichael & Maria Fleseriu. (2012) Mifepristone: is there a place in the treatment of Cushing’s disease?. Endocrine 44:1, pages 20-32.
Crossref
Crossref
Rob van der Pas, Wouter W. de Herder, Leo J. Hofland & Richard A. Feelders. (2013) Recent Developments in Drug Therapy for Cushing’s Disease. Drugs 73:9, pages 907-918.
Crossref
Crossref
Francesco Parillo, Cecilia Dall’Aglio, Gabriele Brecchia, Margherita Maranesi, Angela Polisca, Cristiano Boiti & Massimo Zerani. (2013) Aglepristone (RU534) effects on luteal function of pseudopregnant rabbits: Steroid receptors, enzymatic activities, and hormone productions in corpus luteum and uterus. Animal Reproduction Science 138:1-2, pages 118-132.
Crossref
Crossref
R van der Pas, L J Hofland, J Hofland, A E Taylor, W Arlt, J Steenbergen, P M van Koetsveld, W W de Herder, F H de Jong & R A Feelders. (2012) Fluconazole inhibits human adrenocortical steroidogenesis in vitro. Journal of Endocrinology 215:3, pages 403-412.
Crossref
Crossref
R van der Pas, W W de Herder, L J Hofland & R A Feelders. (2012) New developments in the medical treatment of Cushing's syndrome. Endocrine-Related Cancer 19:6, pages R205-R223.
Crossref
Crossref
María-José Barahona Constanzo & Carlos del Pozo Picó. (2012) Nuevas perspectivas en el tratamiento farmacológico de la enfermedad de Cushing. Endocrinología y Nutrición 59:10, pages 599-605.
Crossref
Crossref
María-José Barahona Constanzo & Carlos del Pozo Picó. (2012) New prospects for drug treatment in Cushing disease. Endocrinología y Nutrición (English Edition) 59:10, pages 599-605.
Crossref
Crossref
Maria Fleseriu. (2012) Medical Management of Persistent and Recurrent Cushing Disease. Neurosurgery Clinics of North America 23:4, pages 653-668.
Crossref
Crossref
Maria Fleseriu & Stephan Petersenn. (2012) Medical management of Cushing’s disease: what is the future?. Pituitary 15:3, pages 330-341.
Crossref
Crossref
Maria Fleseriu, Beverly M. K. Biller, James W. Findling, Mark E. Molitch, David E. Schteingart, Coleman Gross, Richard Auchus, Timothy Bailey, Beverly M. K. Biller, Ty Carroll, Kathleen Colleran, Henry Fein, James W. Findling, Maria Fleseriu, Amir Hamrahian, Laurence Katznelson, Janice Kerr, Mark Kipnes, Lawrence Kirschner, Christian Koch, Sam Lerman, Timothy Lyons, Michael McPhaul, Mark E. Molitch, David E. Schteingart, T. Brooks VaughanIIIIII & Roy Weiss. (2012) Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome. The Journal of Clinical Endocrinology & Metabolism 97:6, pages 2039-2049.
Crossref
Crossref
Jens Heyn, Carolin Geiger, Christian L. Hinske, Josef Briegel & Florian Weis. (2011) Medical suppression of hypercortisolemia in Cushing’s syndrome with particular consideration of etomidate. Pituitary 15:2, pages 117-125.
Crossref
Crossref
S T Sharma & L K Nieman. (2012) Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion. European Journal of Endocrinology 166:3, pages 531-536.
Crossref
Crossref
John H. Suh, Sam T. Chao & Robert J. Weil. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology
493
509
.
Robert F. Gagel. 2012. Goldman's Cecil Medicine. Goldman's Cecil Medicine
1187
1192
.
Nestoras Mathioudakis & Roberto Salvatori. 2012. Schmidek and Sweet Operative Neurosurgical Techniques. Schmidek and Sweet Operative Neurosurgical Techniques
203
214
.
Juergen Sandow. 2003. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Nicholas A. Tritos, Beverly M. K. Biller & Brooke Swearingen. (2011) Management of Cushing disease. Nature Reviews Endocrinology 7:5, pages 279-289.
Crossref
Crossref
Angus R. Brown, Michael Bosies, Helen Cameron, John Clark, Angela Cowley, Mark Craighead, Moira A. Elmore, Alistair Firth, Richard Goodwin, Susan Goutcher, Emma Grant, Morag Grassie, Simon J.A. Grove, Niall M. Hamilton, Hannah Hampson, Alison Hillier, Koc-Kan Ho, Michael Kiczun, Celia Kingsbury, Steven G. Kultgen, Peter T.A. Littlewood, Scott J. Lusher, Susan MacDonald, Lorraine McIntosh, Theresa McIntyre, Ashvin Mistry, J. Richard Morphy, Olaf Nimz, Michael Ohlmeyer, Jack Pick, Zoran Rankovic, Brad Sherborne, Alasdair Smith, Michael Speake, Gayle Spinks, Fiona Thomson, Lynn Watson & Mark Weston. (2011) Discovery and optimisation of a selective non-steroidal glucocorticoid receptor antagonist. Bioorganic & Medicinal Chemistry Letters 21:1, pages 137-140.
Crossref
Crossref
Jürgen Sandow. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
489
521
.
Pedro A. Jose, Patricio Soares-da-Silva, Gilbert M. Eisner & Robin A. Felder. (2010) Dopamine and G protein-coupled receptor kinase 4 in the kidney: Role in blood pressure regulation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1802:12, pages 1259-1267.
Crossref
Crossref
Karen J. Loechner, James T. McLaughlin & Ali S. Calikoglu. (2010) Alternative Strategies for the Treatment of Classical Congenital Adrenal Hyperplasia: Pitfalls and Promises. International Journal of Pediatric Endocrinology 2010, pages 1-10.
Crossref
Crossref